Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939560 · ClinicalTrials.gov registry record · NA
TMS for Adults With Autism and Depression
A NA study of Depression and Major Depressive Disorder, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02939560: Completed NA study of Depression and Major Depressive Disorder, sponsored by Medical University of South Carolina.
NCT02939560 is a NA study of Depression and Major Depressive Disorder that has completed, run by Medical University of South Carolina. The registered enrollment target is 13 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02939560, a NA study of Depression and Major Depressive Disorder, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to investigate whether a standard rTMS protocol for depression, including multiple sessions applied to left dorsolateral prefrontal cortex (DLPFC) results in reduction of depressive symptoms for adult patients with ASD and MDD (Aim 1). The secondary goal is to investigate and whether there is any beneficial reduction in the core symptoms of autism (Aim 2).
Primary Outcome
Hamilton Depression Rating Scale (HAM-D) with 17 questions. Minimum score = 0, maximum 53. Higher scores mean more severe depression.
Conditions Studied
Interventions
- DEVICE NeuroStar® TMS device (Neuronetics, Atlanta, GA)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-09-20 |
| Phase | NA |
What the finished NCT02939560 record still lists
NCT02939560 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which NeuroStar® TMS device (Neuronetics, Atlanta, GA) is the first listed.
NCT02939560 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02939560 about?
NCT02939560 is a clinical study titled "TMS for Adults With Autism and Depression". The goal of this proposal is to investigate whether a standard rTMS protocol for depression, including multiple sessions applied to left dorsolateral prefrontal cortex (DLPFC) results in reduction of depressive symptoms for adult patients with ASD and MDD (Aim 1). The secondary goal is to investigat...
What is the current status of trial NCT02939560?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-09. Estimated completion is 2018-09-20.
What conditions does trial NCT02939560 study?
This clinical trial studies the following conditions: Depression, Major Depressive Disorder, Autism Spectrum Disorder, Depressive Disorder.
What interventions are being tested in trial NCT02939560?
The interventions under investigation include: NeuroStar® TMS device (Neuronetics, Atlanta, GA) (DEVICE).
Who is sponsoring clinical trial NCT02939560?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02939560 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02939560's enrollment target sits among peer trials
13 651st of 679 higher than 27 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia